165 related articles for article (PubMed ID: 11599184)
1. [Pulmonary hypertension screening in systemic scleroderma: a cohort study of 67 patients].
Launay D; Hachulla E; Hatron PY; Michon-Pasturel U; Hebbar M; Queyrel V; Goullard L; Robin S; Rémy-Jardin M; Devulder B
Rev Med Interne; 2001 Sep; 22(9):819-29. PubMed ID: 11599184
[TBL] [Abstract][Full Text] [Related]
2. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis.
Scorza R; Caronni M; Bazzi S; Nador F; Beretta L; Antonioli R; Origgi L; Ponti A; Marchini M; Vanoli M
Ann N Y Acad Sci; 2002 Jun; 966():238-46. PubMed ID: 12114278
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals--a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes.
Kanski M; Arheden H; Wuttge DM; Bozovic G; Hesselstrand R; Ugander M
J Cardiovasc Magn Reson; 2013 Sep; 15(1):86. PubMed ID: 24066703
[TBL] [Abstract][Full Text] [Related]
4. [Severe isolated pulmonary hypertension as main manifestation of Crest syndrome].
Arenas Gracia M; Ruiz Riquelme J; Tovar Martínez A; Martínez López V; Calduch Broseta JV
An Med Interna; 2000 Jul; 17(7):369-71. PubMed ID: 10981335
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary hypertension in patients with systemic scleroderma with CREST-syndrome and without it].
Karoli NA; Rebrov AP; Orlova EE
Ter Arkh; 2004; 76(5):15-8. PubMed ID: 15230125
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma).
Salerni R; Rodnan GP; Leon DF; Shaver JA
Ann Intern Med; 1977 Apr; 86(4):394-9. PubMed ID: 848800
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary hypertension in the CREST syndrome: variant of systemic sclerosis (scleroderma)--a case report.
Lie JT
Angiology; 1989 Aug; 40(8):764-7. PubMed ID: 2757266
[TBL] [Abstract][Full Text] [Related]
8. Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?
Corzo P; Pros A; Martinez-Llorens J; Molina L; Ling SF; Balcells E
Clin Rheumatol; 2018 Dec; 37(12):3365-3371. PubMed ID: 30368639
[TBL] [Abstract][Full Text] [Related]
9. Determinants of pulmonary arterial hypertension in scleroderma.
Plastiras SC; Karadimitrakis SP; Kampolis C; Moutsopoulos HM; Tzelepis GE
Semin Arthritis Rheum; 2007 Jun; 36(6):392-6. PubMed ID: 17204309
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis.
Ungerer RG; Tashkin DP; Furst D; Clements PJ; Gong H; Bein M; Smith JW; Roberts N; Cabeen W
Am J Med; 1983 Jul; 75(1):65-74. PubMed ID: 6859087
[TBL] [Abstract][Full Text] [Related]
11. Isolated diffusing capacity reduction in systemic sclerosis.
Steen VD; Graham G; Conte C; Owens G; Medsger TA
Arthritis Rheum; 1992 Jul; 35(7):765-70. PubMed ID: 1622414
[TBL] [Abstract][Full Text] [Related]
12. Stress Doppler echocardiography in systemic sclerosis: evidence for a role in the prediction of pulmonary hypertension.
Codullo V; Caporali R; Cuomo G; Ghio S; D'Alto M; Fusetti C; Borgogno E; Montecucco C; Valentini G
Arthritis Rheum; 2013 Sep; 65(9):2403-11. PubMed ID: 23754201
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary hypertension and systemic sclerosis].
Morelli S; De Marzio P; Valesini G; Bonavita MS
G Ital Cardiol; 1993 Sep; 23(9):871-6. PubMed ID: 8119516
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary involvement in systemic sclerosis (scleroderma).
Steen VD; Owens GR; Fino GJ; Rodnan GP; Medsger TA
Arthritis Rheum; 1985 Jul; 28(7):759-67. PubMed ID: 4015723
[TBL] [Abstract][Full Text] [Related]
15. [Lung involvement in systemic sclerosis].
Quadrelli S; Ciallella L; Catalán Pellet AC; Molinari L; Salvado A; Auad C; Spina JC
Medicina (B Aires); 2007; 67(5):429-35. PubMed ID: 18051224
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
Steen VD; Lucas M; Fertig N; Medsger TA
J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients.
Murata I; Takenaka K; Yoshinoya S; Kikuchi K; Kiuchi T; Tanigawa T; Ito K
Chest; 1997 Jan; 111(1):36-43. PubMed ID: 8995990
[TBL] [Abstract][Full Text] [Related]
18. [The clinico-functional characteristics of pulmonary arterial hypertension in systemic scleroderma].
Mirrakhimov MM; Moldotashev IK; Bakeeva ME; Shmidt GF
Ter Arkh; 1994; 66(3):67-71. PubMed ID: 8202858
[TBL] [Abstract][Full Text] [Related]
19. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.
Steen V; Medsger TA
Arthritis Rheum; 2003 Feb; 48(2):516-22. PubMed ID: 12571862
[TBL] [Abstract][Full Text] [Related]
20. [Primary pulmonary hypertension: a rare but often fatal complication of Crest syndrome].
Parent-Woillez K; Hachulla E; Bauters C; Hatron PY; Brouillard M; Rifai A; Devulder B
Rev Med Interne; 1997; 18(2):109-13. PubMed ID: 9092028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
